Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The lack of volume on this shell speaks volumes. 1.8 thousand shares traded so far. So much for the BeaMed connection and the Goldman presentation.
Been waiting for this mess to succeed for years and nothing but failures - from Ehrlich's exaggerated hype that never materialized, to NASDAQ blunder, to Ehrlich hiding the Prurisol results, to the failures of P and K and B for covid, the Beverly Fiasco, to the lack of interest by big pharma in B, to the pathetic infrastructure and its dismantling, to a "company" that has barely any money left to operate, etc. But whether I want this mess to succeed is irrelevant. The real question you should be asking is what has the Traveling Man done to make his operation successful and have the results justified his moves?
Sounds like a good match but why haven't they moved in on B if it is so promising?
This one-man salary drain has about a million dollars left, a CEO who plays several roles, is on extended travel status and is void of any communication skills, has a history of failed or cast off drugs in the greatly diminished pipeline, has exhibited years of puffery promoting his drugs and nothing lived up to the hype, and to date there is no interest in B the wonder drug. And not even one mention by Ehrlich of the Goldman presentation. Low volume and the stock is trading at sub-penny levels. Your optimism is void of reality.
"...there is no money to do anything..." Except pay for the outrageous salaries of the Traveling Man and his sidekick. And most likely Ehrlich's legal team in the Beverly lawsuit.
While on the subject of being foolish, how much have you lost on paper from your investment in this garbage?
So can we also conclude that you are getting paid for pumping this mess or are you just an investor who has lost money and is spreading hope (which never materializes) in an attempt to salvage your investment?
You seem to be big on facts. So where are your facts to support your conclusion? Hopefully, you realize that it is Ehrlich, with his history of blunders, lies, fiascos, and failed pipeline, that has caused this mess to eventually reach the sub-penny level and not recover. This one-man buffoon has around a million dollars left to run a public company and yet he is still paying an outrageous salary to himself and his stooge for being a caretaker to a shell. Nobody seems to want B despite all of these patents, studies, papers being mentioned. And BeaMed is probably a year away from doing anything worthwhile. Ehrlich has disappeared, apparently noting that he is on travel status - either a lie, he doesn't take the time to change his message or he has been on travel status for months (which is not a good look for a CEO of a failing "company"). So start placing the blame on the real cause - Ehrlich and his failing operation - and not a message board poster.
LOL. An 11 year investor! You must have lost so much money, at least on paper. But keep believing in Ehrlich and this sub-penny mess and blame everyone other than Ehrlich and his one-man fiasco.
As far as predicting gloom and doom, check the share price. From almost $5 to sub-penny, gloom and doom is already here. Or would you call the state of this mess and its downfall happiness and joy? Reality is still an option.
Look at how this one-man operation has collapsed and the current share price. Now that should scare you.
You seem to be losing at everything. 007...that's about the price of this mess.
Good morning, 007. Any thoughts on why Ehrlich used to mention these types of presentations in press releases or updates but is no longer providing any insights?
When Ehrlich was still coherent and not on long-term travel status, at minimum he would have utilized the Update Section of the now cobwebbed website for anything he believed was noteworthy. The last post on that section was in July 2022, which provides some insight into the stale status of this mess. Did Absentee Ehrlich even mention the presentation or was it Frenchbroad? Can't recall.
So how did Goldman's presentation go? It obviously had zero effect on the stock price and not a peep out of Rip Van Ehrlich. Or maybe he is too busy traveling as per his voice message.
Wow. What a keen eye. Now maybe you can find those two missing press releases you were boasting about in July. Plus or minus, the price of this mess is in the garbage.
Not sure what this has to do with IPIX. Maybe Ehrlich should have thrown away the "company" money into this venture instead of BeaMed. If neoLaser is so great, why did they need Ehrlich's money for their other project? If BeaMed is so promising, why did they allow the outsider to step in? Very doubtful that Empty Head/Empty Pockets Ehrlich will get his money back.
The question now is how much is the IPIX shell worth and does anyone want it. Maybe the two who bilked Ehrlich out of $4 million will want to take one of their companies public.
In the "old days," Hypemaster Ehrlich would have been all over this presentation. Today, nothing (not that his hyping would have changed anything). Seems like even he realizes all is lost.
Should be an easy accounting task - virtually no money remaining, no money coming in, what little is left is going out to Ehrlich and his crew. and possibly the attorneys representing the "company" in the Beverly Debacle.
GreenGrowth is probably a better fit as Pinnacle's principles were diametrically opposed to Ehrlich's -
"Our firm provides outstanding service to our clients because of our dedication to three underlying principles: professionalism, responsiveness, and quality."
Fully divested or invested, it does not change the status of this mess.
Shareholder meetings - gone. Annual updates - gone. Website updates -gone. Ability to contact the "Company" -gone. That should tell you all you need to know about this disaster. With all the failures and lack of interest by potential buyers/partners in the once "promising" drug line, even Pinocchleo has run out of things to hype. As for Ehrlich's big outside-the-box investment, probably nothing until mid-late 2024. The next time you will hear from that flop of many corporate coats is when the company runs out of money and he can no longer pay himself and his stooges.
LOL. I believe Ehrlich and his hyped-up, failed pipeline and less than stellar performance would win that award every time.
"Do you think Ehrlich is a fit person to be CEO of a public company, given his track record here and elsewhere?"
Ehrlich hid information, lied, made numerous blunders...if this were a properly functioning "company" instead of a one-man controlled show, Ehrlich would have been terminated years ago. Under his pathetic leadership, all that is left is a bare-bones mess that once housed some promising, now departed drugs, a hyped-up drug that has failed in one application and that apparently no big pharma is interested in, and some off-the-grid laser venture that the idiot CEO most likely overpaid for out of desperation. Ehrlich has been an absolute disaster and virtually nobody, especially those who invested on the early hype, can say that this has been a good investment.
Lol. Seriously? Read the wall instead. The writing will tell you all you need to know.
"...as of June 30, 2023, the principal executive officer and principal financial officer of the Company have concluded that the Company’s disclosure controls and procedures were not effective due to the material weakness in the Company’s internal control over financial reporting as of June 30, 2023"'
Is this Ehrlich agreeing with Ehrlich and pointing the finger at Ehrlich?
And how long after Q2 2024, if ever, will Ehrlich be able to recover some of the $4 million. If he continues to pay those outrageous salaries, the company will be broke by then.
Brings to light the time when the idiot Ehrlich had the opportunity to uplist from the OTC but he was too inept to pull it off. Ehrlich the liar can't even admit that his shell is on the pinks and continues to maintain it is on the OTCQB.
In general, there are good and bad, attractive and unattractive companies trading on the OTC. IPIX, prior to 2015 or so, was an attractive company, especially if you bought into the hype. It had a seemingly strong pipeline and an infrastructure that far surpassed today's one- man operation. Now, it is a mess. Virtually no funds, a depleted pipeline, basically a one-man operation. It can't carry out its primary business because it has no funding and the one drug left, while the subject of several studies, has not attracted any major players willing to partner/license with IPIX to develop the drug. Alfasigma has been sitting on their version of B for years with nothing but delays, which tells you what they think of the wonder drug. And BeaMed is a long shot that will most likely not bring in money, if any, for awhile. After Ehrlich peels off salaries, the company will be broke.
So at this point, like all stocks, it's a gamble. But the odds are not in the company's favor. Like putting money on a terrible team to win and get into the playoffs. Could it happen? Possibly but highly unlikely.
Not much opportunity for solid news when the one-man operation is basically a shell and the only "hope" is its investment in another company...and that company most likely won't have anything to report on until mid-late 2024.
Definitely brain dead, like its CEO/CFO/Board President/Secretary/IR rep.
The better question is why aren't those companies spending their money to make a deal for B if B truly has the potential to be an effective drug (assuming the profits once the drug hits the market can justify the development/approval costs)?
Here are facts. B for Covid:Fail. B with Alfasigma: Delay after delay. B with Fox Chase: agreement terminated. Stock price: sub-penny. Subsequent to the first of your 3 press releases mentioned in July, the share price dropped into the sub-penny range. The company has insufficient funds to conduct any clinical trials.
B the Wonder Drug is hyped up by some but it will not live up to the hype. If it was a great as some make it out to be, the stock price would not be in the .00 range heading to .000. All Ehrlich has left is BeaMed and that is a long way away with no guarantee that it will bring in anything for Ehrlich. Ehrlich and his stooges will also eat away at the remaining cash soon. Just a complete mess.
More like once a month and the question would be how long does it take him to transfer money out of the IPIX account for himself and his stooges?
"Brilacidin is currently used in clinical trials as SARS-CoV2 drug."
With the decimation of this Ehrlich mess, I have lost track of the Brilacidin clinical trials. What are the clinical trials that Brilacidin is currently in as a SARS-CoV2 drug? I recall the failed 2021 results but is there another "current" clinical trial or trials?
Wow. Points for disclosing this absolute steal. What would have cost you close to a million a few years ago, you were able to snag for around $2k. Like paying $2k for a diamond ring once valued at a million dollars from a slimy character named Leo the Lizard. Unfortunately, all the diamonds were missing and the gold setting turned out to be a cheap metal. But as long as you are happy, that's all that matters.
Just accept the fact that Leo Lollapaloser's debacle has finally reached the sub-penny range and there is little hope in sight. Often times those rose colored glasses do nothing more than mask reality. This garbage has finally become landfill.
Been waiting for that big deal for the past eight years and nothing. Now, this mess has hit a 52 week low (.006) and is nothing but a shell of its former self. All its drugs are failures, Alfasigma thinks so highly of B that there is nothing but delays. Fox Chase terminated its deal, and CEO invites a no confidence vote. Unfortunately, the end is near. The only question is how much the shell is worth.
Things have definitely changed since then....there was actually a company back in 2013 with a lively pipeline. Now, just a pile of dust. This thing has been going down the tubes in the last several years, marked by pipeline failures, an inept CEO, a shell of a company, etc......